Concepedia

Rakshandra Talpur

RT

Statistics

Publications

3

Citations

1.2K

H-Index

3

Active since

2005

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Rakshandra Talpur is an author at The University of Texas MD Anderson Cancer Center specializing in dermatology, pathology, and medicine.

Top concepts

Publications per year

2005–2017

3

Publications

3

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

Madeleine Duvic, Rakshandra Talpur, Xiao Ni et al. · Blood · 2006 · 1.1K citations · Full text

Clinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides

Iris Wieser, Casey Wang, Silvia Alberti Violetti et al. · Archives of Dermatological Research · 2017 · 45 citations

, , +7

Phase II trial of oral suberoylanilide hydroxamic acid (SAHA) for cutaneous T-cell lymphoma (CTCL) unresponsive to conventional therapy

Madeleine Duvic, Rakshandra Talpur, C. Zhang et al. · Journal of Clinical Oncology · 2005 · 19 citations

, , +17

1–3 of 3